HIIT still king
New 2026 fitness research confirms HIIT paired with structured strength training and weekly programming remains the top approach for fat loss. (insightfulpost.com) High‑intensity bodyweight sessions can deliver major cardiovascular and metabolic benefits without fancy equipment. (exercisedaily.com)
A Jan. 24, 2026 meta‑analysis of 19 randomized controlled trials concluded HIIT yields comparable improvements in body composition to moderate‑intensity continuous training but produced a significant BMI reduction in obese participants (SMD = −0.59 kg/m2) and superior VO2peak gains in obese and sedentary groups. A randomized trial published Nov. 10, 2024 in Frontiers (Obesity) split 40 young women between HIIT alone and combined HIIT+resistance training (3×/week for 8 weeks) and reported the combined group increased muscle mass by a mean difference of 2.75% and improved VO2peak by 1.61 mL·kg−1·min−1 versus HIIT alone. A 2025 systematic review and meta‑analysis of dietary weight‑loss trials found adding resistance exercise did not change total weight loss (mean difference −0.32 kg) but protected fat‑free mass (SMD 0.40, p=0.0003) and increased fat‑mass loss (SMD −0.36, p<0.00001). A low‑cost, whole‑body bodyweight HIIT trial in older adults with metabolic syndrome (n=40; mean age 72.4) used 60‑second efforts at 75–85% max heart rate with 120‑second rests, 3×/week for 8 weeks, and produced ≈20% VO2max increases alongside fasting glucose −32%, HbA1c −35% and triglycerides −39% versus controls. A March 2026 study reported by MedicalXpress from Diabetologia showed eight weeks of HIIT increased mitochondrial cristae density by ~7% after manual analysis of ~11,000 mitochondria, a structural adaptation evident in healthy, overweight and type‑2‑diabetes participants. An umbrella review accepted June 17, 2024 pooled 79 RCTs (2,474 participants) and found interval training reduced body‑fat percentage by a weighted mean difference of −0.77% versus MICT and −1.50% versus control, with larger effects in people with overweight/obesity and in interventions ≥12 weeks.
